MedTrace Logo

Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes

NCT02919397 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-08-09

No results posted yet for this study

Summary

The overall aim of this feasibility trial is to assess the effectiveness of a wearable technology and an e-diabetes prevention programme delivered via a smartphone application, including motivational messaging, in reducing weight and increasing physical activity in people at risk of developing type 2 diabetes.

Conditions

  • Pre-diabetes

Interventions

DEVICE

Wearable technology

Buddi wearable technology will record activity levels, participants will access activity data through smartphone application

BEHAVIORAL

Diabetes Prevention Programme educational material

Educational material accessed through smartphone application

BEHAVIORAL

Motivational messaging

Messages sent via smartphone application

Sponsors & Collaborators

Principal Investigators

  • Khalida Ismail · King's College London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2018-05-25
Completion
2018-07-12

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02919397 on ClinicalTrials.gov